Peter Attia· MD
it shouldn't be lost on anybody that ascvd is the leading cause of death at this point um but you know we understand what drives ascvd so well we really understand the relationship between um lipoproteins hypertension smoking and metabolic health and those are basically the big four drivers of ascvd and there are certainly genetic things in there that one has to pay attention to such as LPA familial hyper cholesterol and things like that but again those tend to be relegated down into issues that that can be managed pharmacologically um and so in other words we have a clear understanding of how that disease progresses and we can monitor a person's progress towards that disease we have the biomarkers that predict risk furthermore we have tools like CT angiograms that allow us to at least somewhat grossly look at the anatomy of the coronary arteries and get a sense of Advanced disease might be